PYXS
Pyxis Oncology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.76
+4.76%Next report
Analyst consensus
- Next report date
- Nov 2, 2026
- EPS estimate
- -$0.27
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.40
- EPS estimate
- -$0.35
- Revenue actual
- —
- Revenue estimate
- $33.3K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +3.5%
- Revenue beats (12Q)
- 1
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $12
- PT range
- $8.00 – $19
- Analysts
- 3
3 Buy0 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.35 | -$0.40 | Miss -14.29% | — |
| May 14, 2026 | -$0.35 | -$0.37 | Miss -5.71% | — |
| Mar 23, 2026 | -$0.35 | -$0.29 | Beat 17.14% | — |
| Aug 14, 2025 | -$0.36 | -$0.30 | Beat 16.67% | $2.8M |
| May 15, 2025 | -$0.29 | -$0.35 | Miss -20.69% | — |
| Mar 18, 2025 | -$0.33 | -$0.32 | Beat 3.03% | $3.4M |
| Aug 14, 2024 | -$0.33 | -$0.29 | Beat 12.12% | — |
| Mar 21, 2024 | -$0.49 | -$0.33 | Beat 32.65% | $3.4M |
| Aug 11, 2023 | -$0.66 | -$0.41 | Beat 37.88% | — |
| May 11, 2023 | -$0.84 | -$0.54 | Beat 35.71% | — |
| Mar 22, 2023 | -$0.85 | -$1.04 | Miss -22.35% | — |
| Nov 1, 2022 | -$0.76 | -$0.85 | Miss -11.84% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 2, 2026